Ho Lin (Jack, ζ θ΅«) is an accomplished scientist and educator with expertise in cell biology, neurobiology, pharmacology, reproduction, endocrinology, and cancer biology. Currently serving as the Executive Director of the Science & Technology Division at the Taipei Economic & Cultural Office in Australia and a Distinguished Professor at the Department of Life Sciences, National Chung Hsing University (NCHU), Taiwan, Ho Lin has made significant contributions to the field of biomedical research through his academic pursuits, administrative roles, and collaborative projects. With a background in physiology from National Yang Ming University and biology from Tunghai University, Ho Lin has a strong foundation in both theoretical knowledge and practical research methodologies.
Author Metrics:
Ho Lin has a prolific publication record, with numerous articles published in prestigious scientific journals. As an established researcher, he has contributed to advancing scientific knowledge in various areas of biology and medicine. His publications have been cited extensively, reflecting the impact of his work within the scientific community. Additionally, Ho Lin’s expertise is recognized through his editorial roles in esteemed journals and his participation in scholarly activities such as peer review and guest editing.
Scopus Profile
ORCID Profile
Citations: 2,207 across 1,858 documents
h-index: 27
Number of Documents Authored: 85
Education:
Ho Lin earned his Doctor of Philosophy (Ph.D.) in Physiology from National Yang Ming University and his Bachelor of Science (B.S.) in Biology from Tunghai University. His academic journey provided him with a solid foundation in biomedical sciences, shaping his subsequent career in research and academia. Through rigorous training and interdisciplinary studies, Ho Lin developed expertise in multiple fields, enabling him to conduct innovative research and mentor aspiring scientists.
Research Focus:
Ho Lin’s research interests encompass hormone receptors in cancer biology, novel functions of hormone receptors, and neurobiology. His investigations aim to unravel the molecular mechanisms underlying disease pathogenesis and identify potential therapeutic targets. By elucidating the roles of hormone receptors in cancer progression and exploring their diverse functions in physiological processes, Ho Lin contributes to the development of novel treatment strategies and diagnostic tools.
Professional Journey:
Ho Lin’s professional journey spans various academic and administrative roles, reflecting his commitment to advancing scientific knowledge and fostering academic excellence. From his early career as a postdoctoral fellow at the National Health Research Institutes to his current positions as an Executive Director and Distinguished Professor, Ho Lin has demonstrated leadership, expertise, and dedication to his field. His contributions to education, research, and institutional governance have earned him recognition and respect within the scientific community.
Honors & Awards:
Throughout his career, Ho Lin has received numerous honors and awards in recognition of his outstanding contributions to science and academia. These accolades include the NCHU Distinguished Professorship, Distinguished Mentorship, and grants for distinguished young scholars. Ho Lin’s achievements reflect his excellence in research, teaching, and mentorship, inspiring future generations of scientists and contributing to the advancement of biomedical sciences.
Publications Noted & Contributions:
Ho Lin’s publications are noted for their significance in advancing scientific knowledge and addressing critical questions in biology and medicine. His research contributions span a wide range of topics, including hormone receptor signaling, cancer biology, neurobiology, and pharmacology. Through his publications, Ho Lin has disseminated novel findings, proposed innovative hypotheses, and contributed to the scientific discourse on various biological processes and disease mechanisms.
Metformin alters dendrite development and synaptic plasticity in rat cortical neurons
Published in Biochemical and Biophysical Research Communications, May 2024.
DOI: 10.1016/j.bbrc.2024.149874
Contributors: Muhammet Oner, Pang-Ting Cheng, Hsin-Yi Wang, Mei-Chih Chen, Ho Lin
Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways
Published in Toxicology in Vitro, December 2023.
DOI: 10.1016/j.tiv.2023.105768
Contributors: Chieh-Lin Jerry Teng, Pang-Ting Cheng, Yu-Chiao Cheng, Jia-Rung Tsai, Mei-Chih Chen, Ho Lin
RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells
Published in American Journal of Physiology-Cell Physiology, November 1, 2023.
DOI: 10.1152/ajpcell.00494.2022
Contributors: Wan-Ling Liao, Ho Lin, Yu-Hsuan Li, Tsung-Ying Yang, Mei-Chih Chen
Impacts of androgen pathway manipulation on patients with lung cancer
Published in Journal of Clinical Oncology, June 1, 2023.
DOI: 10.1200/jco.2023.41.16_suppl.e21010
Contributors: Po-Hsin Lee, Jeng-Sen Tseng, Yen-Hsiang Huang, Yu-Wei Hsu, Kuo-Hsuan Hsu, Tsung-Ying Yang, Ho Lin
Abstract A12: Androgen receptor inhibition is involved in Finasteride-reduced AML cell proliferation
Published in Blood Cancer Discovery, May 1, 2023.
DOI: 10.1158/2643-3249.aml23-a12
Contributors: Pang-Ting Cheng, Chieh-Lin Jerry Teng, Yu-Chiao Cheng, Mei-Chih Chen, Ho Lin
Research Timeline:
Ho Lin’s research timeline reflects a progressive trajectory characterized by continuous growth, innovation, and collaboration. From his early explorations as a graduate student to his current leadership roles, Ho Lin’s research journey has been marked by significant achievements, breakthroughs, and interdisciplinary collaborations. Through a combination of basic and translational research, Ho Lin has made notable contributions to understanding disease pathogenesis and developing therapeutic interventions.
Collaborations and Projects:
Ho Lin has actively engaged in collaborative projects with researchers and institutions worldwide, leveraging collective expertise and resources to address complex scientific challenges. His collaborations encompass multidisciplinary teams and interdisciplinary approaches, fostering innovation and knowledge exchange. By collaborating with diverse stakeholders, Ho Lin promotes synergistic research efforts and accelerates the translation of scientific discoveries into clinical applications.
